Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome

Summary

This is a multicenter, open-label, single-arm clinical trial. A total of 100 participants with short bowel syndrome (SBS) receiving parenteral nutrition (PN) support are planned to be enrolled. The trial includes a 2-week run-in phase and a 4-week intervention phase, during which participants will receive rhGH injections. A safety follow-up period will then be conducted through Week 52.

Timeline

Start

2024-07-31

Primary completion

2027-04-28

Completion

2028-06-10

Drugs

Indications